APA (7th ed.) Citation

MY, C., HW, K., TH, W., CC, L., JS, C., CH, H., . . . WC, C. (2026). The albumin-bilirubin score predicts outcomes in advanced biliary tract cancer treated with durvalumab immunochemotherapy. The oncologist, 31(6), . https://doi.org/10.1093/oncolo/oyag179

Chicago Style (17th ed.) Citation

MY, Chen, Kou HW, Wu TH, Lan CC, Chen JS, Hsieh CH, Hung YS, and Chou WC. "The Albumin-bilirubin Score Predicts Outcomes in Advanced Biliary Tract Cancer Treated with Durvalumab Immunochemotherapy." The Oncologist 31, no. 6 (2026). https://doi.org/10.1093/oncolo/oyag179.

MLA (9th ed.) Citation

MY, Chen, et al. "The Albumin-bilirubin Score Predicts Outcomes in Advanced Biliary Tract Cancer Treated with Durvalumab Immunochemotherapy." The Oncologist, vol. 31, no. 6, 2026, https://doi.org/10.1093/oncolo/oyag179.